- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 7, 2023Partner Tim Billion Honored With 2023 Appellate Advocacy Award
-
June 6, 2023Super Lawyers Names Five Attorneys to “Southern California Rising Stars” List
-
June 1, 2023Chambers USA Recognizes Five Robins Kaplan Practice Groups and 17 Lawyers in 2023 Guide
-
June 13, 20232023 Probate and Trust Law Section Conference
-
June 14, 2023Leading Through Uncertainty
-
June 15, 2023Enhance Your Super Powers by Clerking
-
May 2023Raoul Shah: Keeping Humanity and Compassion Close
-
May 18, 2023NFT Trademark Defense Comes Down To Licensing Terms
-
April 20, 2023Drafting Subsequent Agreements to Avoid Arbitrability Litigation
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Eric M. Lindenfeld

Eric M. Lindenfeld
Associate

Experience
Eric Lindenfeld is a member of the firm’s Mass Tort Practice Group who focuses his practice on representing individuals who have been harmed by defective pharmaceutical and medical device products. Eric has played an integral role in multidistrict litigation around the country, including in In Re: Abilify, which settled favorably in 2019 for a confidential sum. Eric is also a part of the litigation team in In Re: National Prescription Opiate Litigation, a consolidated suit in the Northern District of Ohio involving the national opioid crisis.
Eric earned his law degree, with honors, from the University of Minnesota. He has authored several scholarly articles in prominent law journals, including in the Yale Journal of Law and Technology and the Food and Drug Law Journal. His publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology and the Food and Drug Administration casebooks.
In his free time, Eric enjoys hiking, watching mind-bending documentaries, spending time with his niece and nephew, and of course, watching the Knicks win basketball games, which is rare.

- Minnesota
- New Jersey
- New York
- U.S. District Court, District of Minnesota
- U.S. District Court, Eastern District of New York
University of Minnesota Law School, J.D., with honors
Queens College, B.A. in Economics
- American Association for Justice
- Pound Civil Justice Institute
- Public Justice Foundation
"Clear Evidence Clarified," Vol.75 Food and Drug Law Journal. 346 (2020)
"Brand Name Preemption," Vol. 72 Food and Drug Law Journal. 4 (2017)
"3D Printing of Medical Devices," 85 UMKC L. Rev. 1 (2016)
"Prescription Drugs and Design Defect Liability," 64 Drake L. Rev. 111 (2016)
"The Unintended Pregnancy Crisis," 17 Marq. Ben. & Soc. Welfare L. Rev. 2 (2016)
"Beyond Preemption of Generic Drug Claims," 45 Sw. L. Rev. 241 (2015)
"Strict Liability and 3D-Printed Medical Devices," Yale J.L. & Tech. (2015)
"Medical Malpractice Non-Economic Damage Caps," 41 T. Marshall L. Rev. 109 (2015)
RESOURCES
PUBLICATIONS
NEWS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.